{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:11:52Z","timestamp":1759104712388,"version":"3.37.3"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00391-016-1143-9","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T08:06:02Z","timestamp":1477469162000},"page":"743-761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clostridium-difficile-Infektion bei geriatrischen Patienten","Clostridium difficile infections in geriatric patients"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-6684","authenticated-orcid":false,"given":"R.","family":"Simmerlein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Basta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"issue":"3","key":"1143_CR1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cger.2007.03.005","volume":"23","author":"SC Castle","year":"2007","unstructured":"Castle SC et\u00a0al (2007) Host resistance and immune responses in advanced age. Clin Geriatr Med 23(3):463\u2013479","journal-title":"Clin Geriatr Med"},{"issue":"11","key":"1143_CR2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1469-0691.2007.01824.x","volume":"13","author":"F Barbut","year":"2007","unstructured":"Barbut F et\u00a0al (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13(11):1048\u20131057","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1143_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molimm.2014.09.005","volume":"63","author":"X Sun","year":"2015","unstructured":"Sun X, Hirota SA (2015) The roles of host and pathogen factors and the innate immune response in the pathogenesis of clostridium difficile infection. Mol Immunol 63(2):193\u2013202","journal-title":"Mol Immunol"},{"issue":"10","key":"1143_CR4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","volume":"145","author":"JG Bartlett","year":"2006","unstructured":"Bartlett JG (2006) Narrative review: the new epidemic of clostridium difficile-associated enteric disease. Ann Intern Med 145(10):758\u2013764","journal-title":"Ann Intern Med"},{"issue":"7","key":"1143_CR5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","volume":"7","author":"M Rupnik","year":"2009","unstructured":"Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7(7):526\u2013536","journal-title":"Nat Rev Microbiol"},{"key":"1143_CR6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archpedi.1935.01970020105010","volume":"49","author":"IC Hall","year":"1935","unstructured":"Hall IC, O\u2019Toole E (1935) Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, bacillus difficilis. Am J Dis Child 49:390\u2013402","journal-title":"Am J Dis Child"},{"issue":"10","key":"1143_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","volume":"298","author":"JG Bartlett","year":"1978","unstructured":"Bartlett JG et al (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298(10):531\u2013534","journal-title":"N Engl J Med"},{"issue":"24","key":"1143_CR8","first-page":"2369","volume":"372","author":"FC Lessa","year":"2015","unstructured":"Lessa FC, Winston LG, McDonald LC (2015) Burden of clostridium difficile infection in the United States. N\u00a0Engl J Med 372(24):2369\u20132370","journal-title":"N Engl J Med"},{"issue":"4","key":"1143_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3201\/eid1404.071023","volume":"14","author":"F Burckhardt","year":"2008","unstructured":"Burckhardt F et\u00a0al (2008) Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 14(4):691\u2013692","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1143_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3201\/eid1301.060611","volume":"13","author":"RP Vonberg","year":"2007","unstructured":"Vonberg RP, Schwab F, Gastmeier P (2007) Clostridium difficile in discharged inpatients. Germany Emerg Infect Dis 13(1):179\u2013180","journal-title":"Germany Emerg Infect Dis"},{"key":"1143_CR11","first-page":"119","volume":"15","author":"RKI","year":"2008","unstructured":"RKI (2008) Clostridium-difficile-assoziierte Diarrhoe: Zunehmende Inzidenz in Deutschland. Epid Bull 15:119","journal-title":"Epid Bull"},{"key":"1143_CR12","volume-title":"Clostridium-difficile-assoziierte Diarrh\u00f6: Zunehmende Inzidenz in Deutschland. Epidemiologisches Bulletin","author":"RKI","year":"2008","unstructured":"RKI (2008) Clostridium-difficile-assoziierte Diarrh\u00f6: Zunehmende Inzidenz in Deutschland. Epidemiologisches Bulletin. https:\/\/www.google.de\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwji7NLgq9_MAhVLOxoKHXQVBrQQFggkMAA&url=https%3A%2F%2Fwww.rki.de%2FDE%2FContent%2FInfekt%2FEpidBull%2FArchiv%2F2008%2FAusgaben%2F15_08.pdf%3F__blob%3DpublicationFile&usg=AFQjCNFpNAHMwAfKrsei8 ns9seaTGDH3Dg&cad=rja"},{"issue":"23","key":"1143_CR13","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","volume":"294","author":"S Dial","year":"2005","unstructured":"Dial S et al (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294(23):2989\u20132995","journal-title":"JAMA"},{"key":"1143_CR14","volume-title":"Results of the mandatory Clostridium difficile reporting scheme","author":"HP Agency","year":"2007","unstructured":"Agency HP (2007) Results of the mandatory Clostridium difficile reporting scheme. http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@en\/documents\/digitalasset\/dh_078126.pdf"},{"issue":"2","key":"1143_CR15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkn163","volume":"62","author":"MH Wilcox","year":"2008","unstructured":"Wilcox MH et al (2008) A case-control study of community-associated clostridium difficile infection. J Antimicrob Chemother 62(2):388\u2013396","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1143_CR16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid1205.051350","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ et\u00a0al (2006) Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 12(5):827\u2013830","journal-title":"Emerg Infect Dis"},{"issue":"9759","key":"1143_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","volume":"377","author":"MP Bauer","year":"2011","unstructured":"Bauer MP et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63\u201373","journal-title":"Lancet"},{"issue":"5","key":"1143_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10096-008-0655-7","volume":"28","author":"K Graf","year":"2009","unstructured":"Graf K et al (2009) An outbreak of clostridium difficile-associated disease (CDAD) in a German university hospital. Eur J Clin Microbiol Infect Dis 28(5):543\u2013545","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1143_CR19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","volume":"47","author":"A Goorhuis","year":"2008","unstructured":"Goorhuis A et\u00a0al (2008) Emergence of clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47(9):1162\u20131170","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1143_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens Jr.","year":"2008","unstructured":"Owens RC Jr. et al (2008) Antimicrobial-associated risk factors for clostridium difficile infection. Clin Infect Dis 46(Suppl 1):19\u201331","journal-title":"Clin Infect Dis"},{"issue":"e009316","key":"1143_CR21","first-page":"10","volume":"5","author":"A Ticinesi","year":"2015","unstructured":"Ticinesi A et\u00a0al (2015) Multimorbidity in elderly hospitalised patients and risk of clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS). BMJ Open 5(e009316):10","journal-title":"BMJ Open"},{"issue":"4","key":"1143_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/ahe.13.37","volume":"9","author":"RL Jump","year":"2013","unstructured":"Jump RL (2013) Infection in older adults. Aging health 9(4):403\u2013414","journal-title":"Aging health"},{"issue":"9","key":"1143_CR23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","volume":"170","author":"MD Howell","year":"2010","unstructured":"Howell MD et\u00a0al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection. Arch Intern Med 170(9):784\u2013790","journal-title":"Arch Intern Med"},{"issue":"e0141779","key":"1143_CR24","first-page":"11","volume":"10","author":"A Delcher","year":"2015","unstructured":"Delcher A et\u00a0al (2015) Multimorbidities and overprescription of proton pump inhibitors in older patients. PLOS ONE 10(e0141779):11","journal-title":"PLOS ONE"},{"issue":"23","key":"1143_CR25","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"VG Loo","year":"2005","unstructured":"Loo VG et al (2005) A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353(23):2442\u20132449","journal-title":"N Engl J Med"},{"issue":"18","key":"1143_CR26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","volume":"365","author":"VG Loo","year":"2011","unstructured":"Loo VG et\u00a0al (2011) Host and pathogen factors for clostridium difficile infection and colonization. N Engl J Med 365(18):1693\u20131703","journal-title":"N Engl J Med"},{"key":"1143_CR27","unstructured":"Lucado J, Gould C, Elixhauser A (2012) Clostridium Difficile Infections (CDI) in hospital stays, 2009. Statistical Brief #124"},{"issue":"4","key":"1143_CR28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198901263200402","volume":"320","author":"LV McFarland","year":"1989","unstructured":"McFarland LV et\u00a0al (1989) Nosocomial acquisition of clostridium difficile infection. N Engl J Med 320(4):204\u2013210","journal-title":"N Engl J Med"},{"issue":"5","key":"1143_CR29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/659765","volume":"32","author":"DM Guerrero","year":"2011","unstructured":"Guerrero DM et al (2011) Clostridium difficile infection in a department of veterans affairs long-term care facility. Infect Control Hosp Epidemiol 32(5):513\u2013515","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1143_CR30","series-title":"Statistical Brief #121","volume-title":"Readmissions for chronic obstructive pulmonary disease, 2008","author":"A Elixhauser","year":"2006","unstructured":"Elixhauser A, Au DH, Podulka J (2006) Readmissions for chronic obstructive pulmonary disease, 2008. Statistical Brief #121."},{"key":"1143_CR31","series-title":"Statistical Brief #145","volume-title":"Readmissions following hospitalizations with clostridium difficile infections, 2009","author":"A Elixhauser","year":"2006","unstructured":"Elixhauser A, Steiner C, Gould C (2006) Readmissions following hospitalizations with clostridium difficile infections, 2009. Statistical Brief #145."},{"issue":"1","key":"1143_CR32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MCO.0b013e3282f2bfdf","volume":"11","author":"Y Guigoz","year":"2008","unstructured":"Guigoz Y, Dore J, Schiffrin EJ (2008) The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 11(1):13\u201320","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"11","key":"1143_CR33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1432-2277.2009.00927.x","volume":"22","author":"D Weiskopf","year":"2009","unstructured":"Weiskopf D, Weinberger B, Grubeck-Loebenstein B (2009) The aging of the immune system. Transpl Int 22(11):1041\u20131050","journal-title":"Transpl Int"},{"issue":"5","key":"1143_CR34","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","volume":"184","author":"A Panda","year":"2010","unstructured":"Panda A et al (2010) Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J\u00a0Immunol 184(5):2518\u20132527","journal-title":"J Immunol"},{"issue":"6","key":"1143_CR35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","volume":"342","author":"L Kyne","year":"2000","unstructured":"Kyne L et\u00a0al (2000) Asymptomatic carriage of clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342(6):390\u2013397","journal-title":"N Engl J Med"},{"issue":"6","key":"1143_CR36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF02191869","volume":"245","author":"C Ernst","year":"1995","unstructured":"Ernst C, Angst J (1995) Depression in old age. Is there a real decrease in prevalence? A review. Eur Arch Psychiatry Clin Neurosci 245(6):272\u2013287","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1143_CR37","volume-title":"Depressive Erkrankungen [Gesundheitsberichterstattung \u2013 Themenhefte, September 2010]","author":"Statistisches Bundesamt","year":"2010","unstructured":"Statistisches Bundesamt (2010) Depressive Erkrankungen [Gesundheitsberichterstattung \u2013 Themenhefte, September 2010]. http:\/\/www.gbe-bund.de\/gbe10\/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=0&p_knoten=FID&p_sprache=D&p_suchstring=13165#m85"},{"issue":"6","key":"1143_CR38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2036.2008.03924.x","volume":"29","author":"BR Dalton","year":"2009","unstructured":"Dalton BR et al (2009) Proton pump inhibitors increase significantly the risk of clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther 29(6):626\u2013634","journal-title":"Aliment Pharmacol Ther"},{"key":"1143_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1741-7015-11-121","volume":"11","author":"MA Rogers","year":"2013","unstructured":"Rogers MA et\u00a0al (2013) Depression, antidepressant medications, and risk of clostridium difficile infection. BMC Med 11:121","journal-title":"BMC Med"},{"issue":"5","key":"1143_CR40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tim.2008.01.011","volume":"16","author":"T Jank","year":"2008","unstructured":"Jank T, Aktories K (2008) Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 16(5):222\u2013229","journal-title":"Trends Microbiol"},{"key":"1143_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fcimb.2012.00028","volume":"2","author":"RN Pruitt","year":"2012","unstructured":"Pruitt RN, Lacy DB (2012) Toward a structural understanding of clostridium difficile toxins A and B. Front Cell Infect Microbiol 2:28","journal-title":"Front Cell Infect Microbiol"},{"issue":"Pt 1","key":"1143_CR42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1099\/mic.0.27474-0","volume":"151","author":"M Rupnik","year":"2005","unstructured":"Rupnik M et\u00a0al (2005) Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151(Pt 1):199\u2013208","journal-title":"Microbiology"},{"issue":"35","key":"1143_CR43","doi-asserted-by":"crossref","first-page":"25314","DOI":"10.1074\/jbc.M703062200","volume":"282","author":"M Egerer","year":"2007","unstructured":"Egerer M et al (2007) Auto-catalytic cleavage of clostridium difficile toxins A and B depends on cysteine protease activity. J Biol Chem 282(35):25314\u201325321","journal-title":"J Biol Chem"},{"issue":"2","key":"1143_CR44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","volume":"18","author":"DE Voth","year":"2005","unstructured":"Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18(2):247\u2013263","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"1143_CR45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","volume":"9","author":"SJ Heasman","year":"2008","unstructured":"Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9(9):690\u2013701","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1143_CR46","doi-asserted-by":"crossref","first-page":"e69846","DOI":"10.1371\/journal.pone.0069846","volume":"8","author":"NV Jafari","year":"2013","unstructured":"Jafari NV et al (2013) Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s). PLOS ONE 8(7):e69846","journal-title":"PLOS ONE"},{"issue":"12","key":"1143_CR47","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1128\/IAI.02605-14","volume":"82","author":"NV Jafari","year":"2014","unstructured":"Jafari NV et\u00a0al (2014) Host immunity to clostridium difficile PCR ribotype 017 strains. Infect Immun 82(12):4989\u20134996","journal-title":"Infect Immun"},{"issue":"7316","key":"1143_CR48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","volume":"467","author":"SA Kuehne","year":"2010","unstructured":"Kuehne SA et\u00a0al (2010) The role of toxin A and toxin B in clostridium difficile infection. Nature 467(7316):711\u2013713","journal-title":"Nature"},{"issue":"20","key":"1143_CR49","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JB.00731-07","volume":"189","author":"GP Carter","year":"2007","unstructured":"Carter GP et\u00a0al (2007) Binary toxin production in clostridium difficile is regulated by CdtR, a LytTR family response regulator. J\u00a0Bacteriol 189(20):7290\u20137301","journal-title":"J Bacteriol"},{"issue":"7242","key":"1143_CR50","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature07822","volume":"458","author":"D Lyras","year":"2009","unstructured":"Lyras D et\u00a0al (2009) Toxin B is essential for virulence of clostridium difficile. Nature 458(7242):1176\u20131179","journal-title":"Nature"},{"issue":"9","key":"1143_CR51","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/CVI.00210-12","volume":"19","author":"M Wullt","year":"2012","unstructured":"Wullt M et\u00a0al (2012) IgG antibody response to toxins A and B in patients with clostridium difficile infection. Clin Vaccine Immunol 19(9):1552\u20131554","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 1","key":"1143_CR52","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","volume":"46","author":"JG Bartlett","year":"2008","unstructured":"Bartlett JG, Gerding DN (2008) Clinical recognition and diagnosis of clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S12\u20138","journal-title":"Clin Infect Dis"},{"issue":"14","key":"1143_CR53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1251918","volume":"135","author":"T Grunewald","year":"2010","unstructured":"Grunewald T et\u00a0al (2010) Clostridium difficile infection. Dtsch Med Wochenschr 135(14):699\u2013703","journal-title":"Dtsch Med Wochenschr"},{"issue":"Suppl 6","key":"1143_CR54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2006.01580.x","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ, Coignard B, Tull P (2006) Emergence of clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2\u201318","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1143_CR55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND et al (2002) Health care \u2013 associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u2013797","journal-title":"Ann Intern Med"},{"key":"1143_CR56","volume-title":"Clostridium difficile: RKI-Ratgeber f\u00fcr \u00c4rzte. 2009","author":"RKI","year":"2011","unstructured":"RKI (2011) Clostridium difficile: RKI-Ratgeber f\u00fcr \u00c4rzte. 2009. http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Clostridium.html?nn=2393714"},{"issue":"2","key":"1143_CR57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3949\/ccjm.73.2.187","volume":"73","author":"RH Sunenshine","year":"2006","unstructured":"Sunenshine RH, McDonald LC (2006) Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 73(2):187\u2013197","journal-title":"Cleve Clin J Med"},{"issue":"27","key":"1143_CR58","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.3748\/wjg.14.4338","volume":"14","author":"C Hardt","year":"2008","unstructured":"Hardt C et al (2008) Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C\u2011reactive protein. World J Gastroenterol 14(27):4338\u20134341","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1143_CR59","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","volume":"15","author":"MP Bauer","year":"2009","unstructured":"Bauer MP, Kuijper EJ, van Dissel JT (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15(12):1067\u20131079","journal-title":"Clin Microbiol Infect"},{"key":"1143_CR60","volume-title":"S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple","author":"DGVS","year":"2015","unstructured":"DGVS (2015) S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple. http:\/\/www.dgvs.de\/fileadmin\/user_upload\/Leitlinien\/Gastrointestinale_Infektionen_und_Morbus_Whipple\/S2k-Leitlinie_Gastrointestinale_Infektionen_und_Morbus_Whipple_20_02_2015.pdf"},{"issue":"Suppl 2","key":"1143_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","volume":"20","author":"SB Debast","year":"2014","unstructured":"Debast SB, Bauer MP, Kuijper EJ (2014) European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for clostridium difficile infection. Clin Microbiol Infect 20(Suppl 2):1\u201326","journal-title":"Clin Microbiol Infect"},{"key":"1143_CR62","doi-asserted-by":"publisher","unstructured":"Weis S et\u00a0al (2014) Clostridium difficile infection (CDI) in the course of time \u2013 an issue only for the internist? Zentralbl Chir 139. doi: 10.1055\/s-0034-1368432","DOI":"10.1055\/s-0034-1368432"},{"issue":"6","key":"1143_CR63","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/gerona\/60.6.748","volume":"60","author":"DM Fick","year":"2005","unstructured":"Fick DM et al (2005) Delirium superimposed on dementia in a community-dwelling managed care population: a 3\u2011year retrospective study of occurrence, costs, and utilization. J Gerontol A Biol Sci Med Sci 60(6):748\u2013753","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"21","key":"1143_CR64","first-page":"391","volume":"109","author":"S Lorenzl","year":"2012","unstructured":"Lorenzl S, Fusgen I, Noachtar S (2012) Acute confusional States in the elderly \u2013 diagnosis and treatment. Dtsch Arztebl Int 109(21):391\u2013399","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"1143_CR65","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0885-3924(01)00360-8","volume":"22","author":"T Morita","year":"2001","unstructured":"Morita T et\u00a0al (2001) Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J\u00a0Pain Symptom Manage 22(6):997\u20131006","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"1143_CR66","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1503\/cmaj.050978","volume":"173","author":"J Pepin","year":"2005","unstructured":"Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9):1037\u20131042","journal-title":"CMAJ"},{"issue":"Pt 2","key":"1143_CR67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1099\/jmm.0.45844-0","volume":"54","author":"M Delmee","year":"2005","unstructured":"Delmee M et al (2005) Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54(Pt 2):187\u2013191","journal-title":"J Med Microbiol"},{"issue":"6","key":"1143_CR68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.anaerobe.2009.10.005","volume":"15","author":"ML Schmidt","year":"2009","unstructured":"Schmidt ML, Gilligan PH (2009) Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe 15(6):270\u2013273","journal-title":"Anaerobe"},{"issue":"7","key":"1143_CR69","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1572-0241.2003.07482.x","volume":"98","author":"SD Lee","year":"2003","unstructured":"Lee SD et\u00a0al (2003) Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease. Am J Gastroenterol 98(7):1569\u20131572","journal-title":"Am J Gastroenterol"},{"key":"1143_CR70","series-title":"Supplementum","first-page":"1","volume-title":"Clostridium-difficile-Infektion (CDI) Pr\u00e4vention, Diagnostik, Therapie","author":"F Thalhammer","year":"2014","unstructured":"Thalhammer F (2014) Clostridium-difficile-Infektion (CDI) Pr\u00e4vention, Diagnostik, Therapie. Supplementum., S 1\u201312"},{"key":"1143_CR71","unstructured":"Herrmann, PDmM (o. J.) Empfehlungen zur Labordiagnostik bei C.diff.-Infektionen [cited 2015 13. december]; Available from: http:\/\/www.uniklinikum-saarland.de\/de\/einrichtungen\/kliniken_institute\/infektionsmedizin\/medizinische_mikrobiologie_und_hygiene\/konsiliarlabor_clostridium_difficile\/diagnostik\/"},{"key":"1143_CR72","first-page":"125","volume":"14","author":"G Ackermann","year":"2004","unstructured":"Ackermann G (2004) Clostridium difficile \u2013 Aktueller Stand Teil I: Epidemiologie, Pathogenese, Diagnostik, Therapie, Immunologie und Prophylaxe. Mikrobiologe 14:125\u2013129","journal-title":"Mikrobiologe"},{"issue":"4","key":"1143_CR73","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","volume":"31","author":"CM Surawicz","year":"2000","unstructured":"Surawicz CM et al (2000) The search for a better treatment for recurrent clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31(4):1012\u20131017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1143_CR74","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cid\/cit424","volume":"57","author":"SM Brecher","year":"2013","unstructured":"Brecher SM, Novak-Weekley SM, Nagy E (2013) Laboratory diagnosis of clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 57(8):1175\u20131181","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1143_CR75","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhin.2009.08.014","volume":"74","author":"SD Goldenberg","year":"2010","unstructured":"Goldenberg SD et al (2010) Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic clostridium difficile. J\u00a0Hosp Infect 74(1):48\u201354","journal-title":"J Hosp Infect"},{"issue":"3","key":"1143_CR76","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/JCM.01801-09","volume":"48","author":"SM Novak-Weekley","year":"2010","unstructured":"Novak-Weekley SM et al (2010) Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 48(3):889\u2013893","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1143_CR77","first-page":"287","volume":"373","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT (2015) Clostridium difficile Infection. N\u00a0Engl J Med 373(3):287\u2013288","journal-title":"N Engl J Med"},{"key":"1143_CR78","unstructured":"Lamont JT (2016) Clostridium difficile infection in adults: clinical manifestations and diagnosis"},{"issue":"5","key":"1143_CR79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/504362","volume":"27","author":"JM Boyce","year":"2006","unstructured":"Boyce JM et al (2006) Lack of association between the increased incidence of clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 27(5):479\u2013483","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"43","key":"1143_CR80","first-page":"723","volume":"111","author":"C Lubbert","year":"2014","unstructured":"Lubbert C, John E, von Muller L (2014) Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int 111(43):723\u2013731","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"1143_CR81","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1055\/s-0033-1335505","volume":"51","author":"C Lubbert","year":"2013","unstructured":"Lubbert C et\u00a0al (2013) Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI). Z\u00a0Gastroenterol 51(11):1251\u20131258","journal-title":"Z Gastroenterol"},{"key":"1143_CR82","doi-asserted-by":"publisher","first-page":"CD004610","DOI":"10.1002\/14651858.cd004610.pub4","volume":"9","author":"RL Nelson","year":"2011","unstructured":"Nelson RL et al (2011) Antibiotic treatment for clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 9:CD004610. doi: 10.1002\/14651858.cd004610.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"1143_CR83","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-155-12-201112200-00007","volume":"155","author":"DM Drekonja","year":"2011","unstructured":"Drekonja DM et\u00a0al (2011) Comparative effectiveness of clostridium difficile treatments: a systematic review. Ann Intern Med 155(12):839\u2013847","journal-title":"Ann Intern Med"},{"issue":"4","key":"1143_CR84","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM et\u00a0al (2013) Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol 108(4):478\u2013498 (quiz 499)","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1143_CR85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/dkm113","volume":"60","author":"J Freeman","year":"2007","unstructured":"Freeman J et\u00a0al (2007) Effect of metronidazole on growth and toxin production by epidemic clostridium difficile PCR ribotypes 001 and 027 in a human gut model. J\u00a0Antimicrob Chemother 60(1):83\u201391","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1143_CR86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4166\/kjg.2016.67.2.81","volume":"67","author":"HC Lee","year":"2016","unstructured":"Lee HC et\u00a0al (2016) Clinical outcomes in hospitalized patients with clostridium difficile infection by Age group. Korean J Gastroenterol 67(2):81\u201386","journal-title":"Korean J Gastroenterol"},{"issue":"10","key":"1143_CR87","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/587654","volume":"46","author":"JG Bartlett","year":"2008","unstructured":"Bartlett JG (2008) The case for vancomycin as the preferred drug for treatment of clostridium difficile infection. Clin Infect Dis 46(10):1489\u20131492","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1143_CR88","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","volume":"40","author":"DM Musher","year":"2005","unstructured":"Musher DM et\u00a0al (2005) Relatively poor outcome after treatment of clostridium difficile colitis with metronidazole. Clin Infect Dis 40(11):1586\u20131590","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1143_CR89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","volume":"31","author":"SH Cohen","year":"2010","unstructured":"Cohen SH et\u00a0al (2010) Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431\u2013455","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1143_CR90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(89)90223-4","volume":"86","author":"R Fekety","year":"1989","unstructured":"Fekety R et al (1989) Treatment of antibiotic-associated clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 86(1):15\u201319","journal-title":"Am J Med"},{"issue":"6","key":"1143_CR91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijantimicag.2013.08.013","volume":"42","author":"SW Lam","year":"2013","unstructured":"Lam SW et\u00a0al (2013) Effect of vancomycin dose on treatment outcomes in severe clostridium difficile infection. Int J Antimicrob Agents 42(6):553\u2013558","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"1143_CR92","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/BF02234641","volume":"44","author":"F Friedenberg","year":"2001","unstructured":"Friedenberg F et\u00a0al (2001) Intravenous metronidazole for the treatment of clostridium difficile colitis. Dis Colon Rectum 44(8):1176\u20131180","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"1143_CR93","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bjs.8868","volume":"99","author":"A Bhangu","year":"2012","unstructured":"Bhangu A et al (2012) Systematic review and meta-analysis of outcomes following emergency surgery for clostridium difficile colitis. Br J Surg 99(11):1501\u20131513","journal-title":"Br J Surg"},{"issue":"1","key":"1143_CR94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijsu.2008.11.002","volume":"7","author":"S Chan","year":"2009","unstructured":"Chan S et\u00a0al (2009) Outcomes following colectomy for clostridium difficile colitis. Int J Surg 7(1):78\u201381","journal-title":"Int J Surg"},{"issue":"1","key":"1143_CR95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/SLA.0b013e31828a8eba","volume":"259","author":"DY Lee","year":"2014","unstructured":"Lee DY et al (2014) Predictors of mortality after emergency colectomy for clostridium difficile colitis: an analysis of ACS-NSQIP. Ann Surg 259(1):148\u2013156","journal-title":"Ann Surg"},{"issue":"3","key":"1143_CR96","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/SLA.0b013e31822ade48","volume":"254","author":"MD Neal","year":"2011","unstructured":"Neal MD et\u00a0al (2011) Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg 254(3):423\u2013427 (discussion 427\u20139)","journal-title":"Ann Surg"},{"issue":"6","key":"1143_CR97","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/sur.2012.158","volume":"14","author":"PK Kim","year":"2013","unstructured":"Kim PK et\u00a0al (2013) Intracolonic vancomycin for severe clostridium difficile colitis. Surg Infect (Larchmt) 14(6):532\u2013539","journal-title":"Surg Infect (Larchmt)"},{"issue":"7","key":"1143_CR98","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.00090-08","volume":"52","author":"WN Al-Nassir","year":"2008","unstructured":"Al-Nassir WN et al (2008) Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52(7):2403\u20132406","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1143_CR99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1086\/592710","volume":"30","author":"AK Sethi","year":"2009","unstructured":"Sethi AK et al (2009) Skin and environmental contamination with vancomycin-resistant enterococci in patients receiving oral metronidazole or oral vancomycin treatment for clostridium difficile-associated disease. Infect Control Hosp Epidemiol 30(1):13\u201317","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"1143_CR100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/653613","volume":"31","author":"M Miller","year":"2010","unstructured":"Miller M et al (2010) Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated clostridium difficile infection. Infect Control Hosp Epidemiol 31(7):710\u2013715","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1143_CR101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-010-1411-2","volume":"56","author":"MS Abougergi","year":"2011","unstructured":"Abougergi MS, Kwon JH (2011) Intravenous immunoglobulin for the treatment of clostridium difficile infection: a review. Dig Dis Sci 56(1):19\u201326","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1143_CR102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","volume":"58","author":"S Johnson","year":"2009","unstructured":"Johnson S (2009) Recurrent clostridium difficile infection: a review of risk factors, treatments, and outcomes. J\u00a0Infect 58(6):403\u2013410","journal-title":"J Infect"},{"issue":"6","key":"1143_CR103","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","volume":"42","author":"J Pepin","year":"2006","unstructured":"Pepin J et al (2006) Management and outcomes of a first recurrence of clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42(6):758\u2013764","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"1143_CR104","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cid\/cis462","volume":"55","author":"OA Cornely","year":"2012","unstructured":"Cornely OA et\u00a0al (2012) Treatment of first recurrence of clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 55(Suppl 2):154\u2013161","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"1143_CR105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis338","volume":"55","author":"TJ Louie","year":"2012","unstructured":"Louie TJ et\u00a0al (2012) Fidaxomicin preserves the intestinal microbiome during and after treatment of clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 55(Suppl 2):132\u2013142","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1143_CR106","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ et\u00a0al (2011) Fidaxomicin versus vancomycin for clostridium difficile infection. N Engl J Med 364(5):422\u2013431","journal-title":"N Engl J Med"},{"issue":"3","key":"1143_CR107","first-page":"83","volume":"19","author":"K Kapoor","year":"1999","unstructured":"Kapoor K et\u00a0al (1999) Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res 19(3):83\u201388","journal-title":"Int J Clin Pharmacol Res"},{"key":"1143_CR108","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","volume":"31","author":"SH Cohen","year":"2010","unstructured":"Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH (2010) Infection Control and Hospital Epidemiology 31 (5):431\u2013455","journal-title":"Infection Control and Hospital Epidemiology"},{"key":"1143_CR109","doi-asserted-by":"publisher","unstructured":"Britt NS et\u00a0al (2014) Tigecycline for the treatment of severe and severe complicated clostridium difficile infection. Infect Dis Ther 3. doi: 10.1007\/s40121-014-0050-x","DOI":"10.1007\/s40121-014-0050-x"},{"issue":"12","key":"1143_CR110","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/599224","volume":"48","author":"BL Herpers","year":"2009","unstructured":"Herpers BL et\u00a0al (2009) Intravenous tigecycline as adjunctive or alternative therapy for severe refractory clostridium difficile infection. Clin Infect Dis 48(12):1732\u20131735","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1143_CR111","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/AAC.04296-14","volume":"59","author":"CM Theriot","year":"2015","unstructured":"Theriot CM et\u00a0al (2015) Effects of tigecycline and vancomycin administration on established clostridium difficile infection. Antimicrob Agents Chemother 59(3):1596\u20131604","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1143_CR112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/apt.12111","volume":"37","author":"E Mattila","year":"2013","unstructured":"Mattila E et\u00a0al (2013) Rifaximin in the treatment of recurrent clostridium difficile infection. Aliment Pharmacol Ther 37(1):122\u2013128","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1143_CR113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1756283X10372985","volume":"3","author":"PP Basu","year":"2010","unstructured":"Basu PP et al (2010) Rifaximin therapy for metronidazole-unresponsive clostridium difficile infection: a prospective pilot trial. Therap Adv Gastroenterol 3(4):221\u2013225","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"1143_CR114","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","volume":"44","author":"S Johnson","year":"2007","unstructured":"Johnson S et al (2007) Interruption of recurrent clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44(6):846\u2013848","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1143_CR115","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B et\u00a0al (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44(5):854\u2013859","journal-title":"Surgery"},{"issue":"5","key":"1143_CR116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E Nood van","year":"2013","unstructured":"van Nood E et\u00a0al (2013) Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 368(5):407\u2013415","journal-title":"N Engl J Med"},{"issue":"10","key":"1143_CR117","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent clostridium difficile infection. Clin Infect Dis 53(10):994\u20131002","journal-title":"Clin Infect Dis"},{"issue":"18","key":"1143_CR118","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2012.3507","volume":"307","author":"S Hempel","year":"2012","unstructured":"Hempel S et al (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307(18):1959\u20131969","journal-title":"JAMA"},{"key":"1143_CR119","doi-asserted-by":"publisher","first-page":"CD004611","DOI":"10.1002\/14651858.cd004611.pub2","volume":"1","author":"A Pillai","year":"2008","unstructured":"Pillai A, Nelson R (2008) Probiotics for treatment of clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 1:CD004611. doi: 10.1002\/14651858.cd004611.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1143_CR120","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","volume":"41","author":"A Enache-Angoulvant","year":"2005","unstructured":"Enache-Angoulvant A, Hennequin C (2005) Invasive saccharomyces infection: a comprehensive review. Clin Infect Dis 41(11):1559\u20131568","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1143_CR121","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","volume":"40","author":"P Munoz","year":"2005","unstructured":"Munoz P et\u00a0al (2005) Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 40(11):1625\u20131634","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1143_CR122","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/ncpgasthep1368","volume":"6","author":"MG Besselink","year":"2009","unstructured":"Besselink MG et\u00a0al (2009) Probiotic prophylaxis in acute pancreatitis: prudence required. Nat Clin Pract Gastroenterol Hepatol 6(3):E3\u2013E6","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"11","key":"1143_CR123","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/IAI.00982-06","volume":"74","author":"GJ Babcock","year":"2006","unstructured":"Babcock GJ et al (2006) Human monoclonal antibodies directed against toxins A and B prevent clostridium difficile-induced mortality in hamsters. Infect Immun 74(11):6339\u20136347","journal-title":"Infect Immun"},{"issue":"2","key":"1143_CR124","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.02897-14","volume":"83","author":"Z Yang","year":"2015","unstructured":"Yang Z et\u00a0al (2015) Mechanisms of protection against clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab. Infect Immun 83(2):822\u2013831","journal-title":"Infect Immun"},{"issue":"3","key":"1143_CR125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","volume":"362","author":"I Lowy","year":"2010","unstructured":"Lowy I et\u00a0al (2010) Treatment with monoclonal antibodies against clostridium difficile toxins. N Engl J Med 362(3):197\u2013205","journal-title":"N Engl J Med"},{"key":"1143_CR126","volume-title":"Pivotal phase 3 studies of bezlotoxumab, Merck\u2019s investigational antitoxin to prevent clostridium difficile infection recurrence, met primary endpoint 2015","author":"Merck & Co","year":"2015","unstructured":"Merck & Co (2015) Pivotal phase 3 studies of bezlotoxumab, Merck\u2019s investigational antitoxin to prevent clostridium difficile infection recurrence, met primary endpoint 2015. http:\/\/www.mercknewsroom.com\/news-release\/research-and-development-news\/pivotal-phase-3-studies-bezlotoxumab-mercks-investigation"},{"key":"1143_CR127","volume-title":"Bezlotoxumab prevents clostridium difficile (C diff) infection recurrence: results of the MODIFY I trial","author":"M Wilcox","year":"2015","unstructured":"Wilcox M (2015) Bezlotoxumab prevents clostridium difficile (C diff) infection recurrence: results of the MODIFY I trial. https:\/\/www.asm.org\/index.php\/asm-events\/icaac2013\/371-news-room\/icaac-releases\/93721-bezlotoxumab-prevents-clostridium-difficile-c-diff-infection-recurrence-results-of-the-modify-i-trial"},{"issue":"4","key":"1143_CR128","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1532-5415.2009.02182.x","volume":"57","author":"ED Cober","year":"2009","unstructured":"Cober ED, Malani PN (2009) Clostridium difficile infection in the \u201eoldest\u201c old: clinical outcomes in patients aged 80 and older. J\u00a0Am Geriatr Soc 57(4):659\u2013662","journal-title":"J Am Geriatr Soc"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-016-1143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-016-1143-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-016-1143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T21:55:08Z","timestamp":1568498108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-016-1143-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1007\/s00391-016-1143-9","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"type":"print","value":"0948-6704"},{"type":"electronic","value":"1435-1269"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}